Search

Your search keyword '"Hessels D"' showing total 178 results

Search Constraints

Start Over You searched for: Author "Hessels D" Remove constraint Author: "Hessels D" Search Limiters Academic (Peer-Reviewed) Journals Remove constraint Search Limiters: Academic (Peer-Reviewed) Journals
178 results on '"Hessels D"'

Search Results

1. Cost-effectiveness of SelectMDx for prostate cancer in four European countries: a comparative modeling study

6. Detection of High-grade Prostate Cancer Using a Urinary Molecular Biomarker-Based Risk Score.

7. Validatie van een nieuwe urinetest voor klinisch significante prostaatkanker.

8. New targets for therapy in prostate cancer: differential display code 3 (DD3(PCA3)), a highly prostate cancer-specific gene

9. 383 Multicenter validation study of a urine-based molecular biomarker algorithm to predict high-grade prostate cancer

10. Identification of a Candidate Gene Panel for the Early Diagnosis of Prostate Cancer

11. The role of PCA3 in the diagnosis of prostate cancer

12. Prospective multicentre evaluation of PCA3 and TMPRSS2-ERG gene fusions as diagnostic and prognostic urinary biomarkers for prostate cancer

13. Prostate cancer antigen 3: diagnostic outcomes in men presenting with urinary prostate cancer antigen 3 scores ≥100

14. Preliminary evaluation of the effect of dutasteride on PCA3 in post-DRE urine sediments: a randomized, open-label, parallel-group pilot study

15. 351 QUATTRO, a four gene prognostic biomarker panel for prostate cancer

16. Rational basis for the combination of PCA3 and TMPRSS2:ERG gene fusion for prostate cancer diagnosis

17. Urinary biomarkers for prostate cancer: a review

18. Recurrent gene fusions in prostate cancer: their clinical implications and uses

19. Biomarkers for the diagnosis of prostatic inflammation in benign prostatic hyperplasia

20. Differential expression of PCA3 and its overlapping PRUNE2 transcript in prostate cancer.

21. Predictive value of PCA3 in urinary sediments in determining clinico-pathological characteristics of prostate cancer.

22. The role of PCA3 in the diagnosis of prostate cancer.

23. The use of PCA3 in the diagnosis of prostate cancer.

24. Detailed analysis of histopathological parameters in radical prostatectomy specimens and PCA3 urine test results.

25. Multifocal urothelial cell cancer and p53 mutation analysis

26. Detection of TMPRSS2-ERG fusion transcripts and prostate cancer antigen 3 in urinary sediments may improve diagnosis of prostate cancer.

27. Polycomb-group oncogenes EZH2, BMI1, and RING1 are overexpressed in prostate cancer with adverse pathologic and clinical features.

28. Molecular PCA3 diagnostics on prostatic fluid.

29. The time-resolved fluorescence-based PCA3 test on urinary sediments after digital rectal examination; a Dutch multicenter validation of the diagnostic performance.

32. Applicability of biomarkers in the early diagnosis of prostate cancer.

34. DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer.

36. DD3(PCA3), a very sensitive and specific marker to detect prostate tumors.

41. 114 THE TIME RESOLVED FLUORESCENCE-BASED PCA3 TEST ON URINARY SEDIMENTS AFTER EXTENDED DIGITAL RECTAL EXAMINATION; A DUTCH MULTICENTER VALIDATION OF THE DIAGNOSTIC PERFORMANCE

43. Comparative analysis of p53 mutations in bladder washings and histologic specimens

44. Rapid microwave stimulated fixation of entire prostatectomy specimens

Catalog

Books, media, physical & digital resources